enGene Holdings Inc. (ENGN) - Dilution Analysis

10-Q filing | 67.3M shares outstanding

8-K filing: enGene Holdings Inc. issued warrants to lenders to purchase common shares in connection with a loan agreement amendment.

10-K filing | 67.0M shares outstanding

10-Q filing | 51.1M shares outstanding

10-Q filing | 51.0M shares outstanding

10-Q filing | 51.0M shares outstanding

10-K filing | 51.0M shares outstanding

S-3 filing: enGene Holdings Inc. is filing a shelf registration statement to offer and sell common shares, preferred shares, debt securities, subscription receipts, warrants to purchase common shares and units or any combination thereof up to an aggregate initial offering price of up to US$300,000,000.

S-3 filing: This prospectus relates to the offer and sale from time to time by the selling securityholders of up to 46,977,183 common shares, 6,289,198 warrants, and up to 8,511,968 common shares issuable upon exercise of the warrants.

10-Q filing | 44.2M shares outstanding

10-Q filing | 44.2M shares outstanding

10-Q filing | 43.6M shares outstanding

S-1/A filing: This S-1/A filing from enGene Holdings Inc. relates to the offer and sale from time to time by the Selling Holders of up to 47,144,548 Common Shares and up to 6,386,589 Warrants. It also relates to up to 9,794,498 Common Shares issuable upon exercise of the Warrants.

10-K filing | 23.2M shares outstanding

S-1/A filing: This is an S-1/A filing for enGene Holdings Inc. related to the offer and sale from time to time by the Selling Holders of up to: (i) 6,462,016 of our Common Shares and 2,783,949 Warrants issued for the consideration described in the succeeding paragraph below in connection with the PIPE Financing and a Non-Redemption Agreement to the PIPE/NRA Investors including FEAC Sponsor or an affiliate thereof; (ii) 14,295,943 Common Shares and 3,602,640 Warrants held by certain Selling Holders party to the Registration Rights Agreement, including FEAC Sponsor or an affiliate thereof, and (iii) 6,386,589 Common Shares that may be obtained by the Selling Holders upon the exercise of the Warrants at an exercise price of $11.50 described in (i)  and (ii) above.

S-1 filing: This is an S-1 filing for enGene Holdings Inc. offering common shares and warrants by selling holders, as well as common shares issuable upon exercise of warrants by the company.